2005•Unpublished venueRequires access

Anti-γc and anti-IL-2Rβ mAbs inhibit donor-antigen reactive T cells proliferation and induce H-Y skin graft acceptance in murine model

Bicheng Chen

Open publisher page 0 citations

Abstract

Objective The is an To investigate whether blocking common cytokine receptor γ chain (γc) signals can induce transplant tolerance.Methods The animals were randomly divided into 3 groups ( n =7 in each). GroupⅠ (control group): C57BL/6 female mice only received H-Y skin grafts. Group Ⅱ: Female recipients received transfusion of splenocytes (5×10 6 cells) from syngeneic male mice on day 7 before H-Y skin grafting. Group Ⅲ: Following donor-splenocytes pretreatment, on the day 2 and 4, female recipients received intraperitoneal injection of mixture of anti-IL-2Rβ mAb (TM-β1) and anti-γc mAbs (i.e., 4G3, 3E12 and TUGm2, 0.5 mg , respectively). On the day 7, H-Y skin grafts were performed.Results All recipients treated with mixture of mAbs in combination with donor-splenocytes transfusion accepted H-Y skin grafts over 100 days without evidence of rejection. Group Ⅰ rejected grafts within 35 days after grafting (MST= 33.42 days) and group Ⅱ rejected grafts within 17 days after grafting (MST= 14.71 days). There were statistically significant diffe- rences among the groups ( P 0.01 ).Conclusion Blockade of γc signaling in combination with donor- splenocytes pretreatment can markedly prolong H-Y skin graft survival, which might be associated with inhibition of antigen-specific T cell proliferation and induction of apoptosis.

About this research paper

What this paper is about

Objective The is an To investigate whether blocking common cytokine receptor γ chain (γc) signals can induce transplant tolerance.Methods The animals were randomly divided into 3 groups ( n =7 in each). GroupⅠ (control group): C57BL/6 female mice only received H-Y skin grafts. Group Ⅱ: Female recipients received transfusion of splenocytes (5×10 6 cells) from syngeneic male mice on day 7 before H-Y skin grafting. Group Ⅲ: Following donor-splenocytes pretreatment, on the day 2 and 4, female recipients received intraperitoneal injection of mixture of anti-IL-2Rβ mAb (TM-β1) and anti-γc mAbs (i.e., 4G3, 3E12 and TUGm2, 0.5 mg , respectively). On the day 7, H-Y skin grafts were performed.Results All recipients treated with mixture of mAbs in combination with donor-splenocytes transfusion accepted H-Y skin grafts over 100 days without evidence of rejection. Group Ⅰ rejected grafts within 35 days after grafting (MST= 33.42 days) and group Ⅱ rejected grafts within 17 days after grafting (MST= 14.71 days). There were statistically significant diffe- rences among the groups ( P 0.01 ).Conclusion Blockade of γc signaling in combination with donor- splenocytes pretreatment can markedly prolong H-Y skin graft survival, which might be associated with inhibition of antigen-specific T cell proliferation and induction of apoptosis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective The is an To investigate whether blocking common cytokine receptor γ chain (γc) signals can induce transplant tolerance.Methods The animals were randomly divided into 3 groups ( n =7 in each). GroupⅠ (control group): C57BL/6 female mice only received H-Y skin grafts. Group Ⅱ: Female recipients received transfusion of splenocytes (5×10 6 cells) from syngeneic male mice on day 7 before H-Y skin grafting. Group Ⅲ: Following donor-splenocytes pretreatment, on the day 2 and 4, female recipients received intraperitoneal injection of mixture of anti-IL-2Rβ mAb (TM-β1) and anti-γc mAbs (i.e., 4G3, 3E12 and TUGm2, 0.5 mg , respectively). On the day 7, H-Y skin grafts were performed.Results All recipients treated with mixture of mAbs in combination with donor-splenocytes transfusion accepted H-Y skin grafts over 100 days without evidence of rejection. Group Ⅰ rejected grafts within 35 days after grafting (MST= 33.42 days) and group Ⅱ rejected grafts within 17 days after grafting (MST= 14.71 days). There were statistically significant diffe- rences among the groups ( P 0.01 ).Conclusion Blockade of γc signaling in combination with donor- splenocytes pretreatment can markedly prolong H-Y skin graft survival, which might be associated with inhibition of antigen-specific T cell proliferation and induction of apoptosis.

Key concepts: Splenocyte, Skin grafting, Medicine, Monoclonal antibody, Intraperitoneal injection, Immunology, Antigen, Group A

Related papers

Back to paper searchBrowse research topicsOriginal source
Anti-γc and anti-IL-2Rβ mAbs inhibit donor-antigen reactive T cells proliferation and induce H-Y skin graft acceptance in murine model — Research Paper | ScholarLens